Cognitive Dysfunction: Feasibility of a Brief Intervention to Help Breast Cancer Survivors

2021 ◽  
Vol 25 (6) ◽  
pp. E69-E76
Author(s):  
Mary Radomski ◽  
Robert Kreiger ◽  
Mattie Anheluk ◽  
Kristin Berling ◽  
Michele Darger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Brief Intervention ◽  
Breast Cancer Survivors

scholarly journals Cognitive Dysfunction in Older Breast Cancer Survivors

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Adele Crouch ◽  
Victoria Champion ◽  
Diane Von Ah
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Breast Cancer Survivors

Quality of life and cognitive dysfunction in breast cancer survivors on a feasibility study of donepezil versus placebo.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 9516-9516
Author(s):  
Julia Lawrence ◽  
Leah Griffin ◽  
Steve Rapp ◽  
Michael J. Messino ◽  
Ernie P. Balcueva ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Feasibility Study ◽  
Breast Cancer Survivors

scholarly journals Comorbidity, Cognitive Dysfunction, Physical Functioning and Quality of Life in Older Breast Cancer Survivors

2021 ◽  
Author(s):  
Adele Crouch ◽  
Victoria Champion ◽  
Diane Von Ah
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Physical Functioning ◽  
Breast Cancer Survivors ◽  
College Education ◽  
Secondary Data ◽  
Well Being

Abstract PurposeOlder breast cancer survivors (BCS) may be at greater risk for cognitive dysfunction and other comorbidities; both of which may be associated with physical and emotional well-being. This study will seek to understand these relationships by examining the association between objective and subjective cognitive dysfunction and physical functioning and quality of life (QoL) and moderated by comorbidities in older BCS. MethodsA secondary data analysis was conducted on using data from 335 BCS (Stage I-IIIA) who were ≥60 years of age, received chemotherapy, and were 3-8 years post-diagnosis. BCS completed a one-time questionnaire and neuropsychological tests of learning, delayed recall, attention, working memory and verbal fluency. Descriptive statistics and separate linear regression analyses testing the relationship of each cognitive assessment on physical functioning and QoL controlling for comorbidities were conducted.ResultsBCS were on average 69.79 (SD=3.34) years old and 5.95 (SD=1.48) years post-diagnosis. Most were stage II (67.7%) at diagnosis, White (93.4%), had at least some college education (51.6%) and reported on average 3 (SD=1.81) comorbidities. All 6 physical functioning models were significant (p<.001); with more comorbidities and worse subjective attention identified as significantly related to decreased physical functioning. One model found worse subjective attention was related to poorer QoL (p<.001). Objective cognitive function measures were not significantly related to physical functioning or QoL. ConclusionsA greater number of comorbidities and poorer subjective attention were related to poorer outcomes and should be integrated into research seeking to determine predictors of physical functioning and QoL in breast cancer survivors.

scholarly journals A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy

2015 ◽  
Vol 10 (1) ◽  
pp. 176-184 ◽  
Author(s):  
J. A. Lawrence ◽  
L. Griffin ◽  
E. P. Balcueva ◽  
D. L. Groteluschen ◽  
T. A. Samuel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Breast Cancer Survivors ◽  
Female Breast Cancer ◽  
Female Breast

A Brief Intervention for Fatigue Management in Breast Cancer Survivors

2008 ◽  
Vol 31 (2) ◽  
pp. 145-159 ◽  
Author(s):  
Lise Fillion ◽  
Pierre Gagnon ◽  
Francine Leblond ◽  
Céline Gélinas ◽  
Josée Savard ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Brief Intervention ◽  
Breast Cancer Survivors ◽  
Fatigue Management

Cognitive Dysfunction and Its Relationship to Quality of Life in Breast Cancer Survivors

2009 ◽  
Vol 36 (3) ◽  
pp. 326-336 ◽  
Author(s):  
Diane Von Ah ◽  
Kathleen M. Russell ◽  
Anna Maria Storniolo ◽  
Janet S. Carpenter
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Breast Cancer Survivors

scholarly journals Chemotherapy-Related Cognitive Dysfunction in Breast Cancer Survivors: A Systematic Review

2021 ◽  
Vol 9 (2) ◽  
pp. 27
Author(s):  
Katherine Jinghua Lin ◽  
Cecile Lengacher ◽  
Carmen Rodriguez ◽  
Laura Szalacha ◽  
Jennifer Wolgemuth
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Breast Cancer Survivors

scholarly journals Comorbidity, cognitive dysfunction, physical functioning, and quality of life in older breast cancer survivors

2021 ◽  
Author(s):  
Adele Crouch ◽  
Victoria L. Champion ◽  
Diane Von Ah
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Cognitive Dysfunction ◽  
Physical Functioning ◽  
Breast Cancer Survivors ◽  
College Education ◽  
Secondary Data ◽  
Well Being

Abstract Purpose Older breast cancer survivors (BCS) may be at greater risk for cognitive dysfunction and other comorbidities; both of which may be associated with physical and emotional well-being. This study will seek to understand these relationships by examining the association between objective and subjective cognitive dysfunction and physical functioning and quality of life (QoL) and moderated by comorbidities in older BCS. Methods A secondary data analysis was conducted on data from 335 BCS (stages I–IIIA) who were ≥ 60 years of age, received chemotherapy, and were 3–8 years post-diagnosis. BCS completed a one-time questionnaire and neuropsychological tests of learning, delayed recall, attention, working memory, and verbal fluency. Descriptive statistics and separate linear regression analyses testing the relationship of each cognitive assessment on physical functioning and QoL controlling for comorbidities were conducted. Results BCS were on average 69.79 (SD = 3.34) years old and 5.95 (SD = 1.48) years post-diagnosis. Most were stage II (67.7%) at diagnosis, White (93.4%), had at least some college education (51.6%), and reported on average 3 (SD = 1.81) comorbidities. All 6 physical functioning models were significant (p < .001), with more comorbidities and worse subjective attention identified as significantly related to decreased physical functioning. One model found worse subjective attention was related to poorer QoL (p < .001). Objective cognitive function measures were not significantly related to physical functioning or QoL. Conclusions A greater number of comorbidities and poorer subjective attention were related to poorer outcomes and should be integrated into research seeking to determine predictors of physical functioning and QoL in breast cancer survivors.

Sign in / Sign up

Export Citation Format

Share Document